Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to revision v3.0.2 from v3.0.1, indicating a minor update with no substantive changes to core content, pricing, or availability. The 'Back to Top' link was removed, but this does not affect the main content.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check19 days agoChange DetectedThe webpage has been updated to include new resources related to myeloid leukemia and other blood disorders, as well as specific medications like decitabine and azacitidine. Additionally, the facility name and location details have been revised, while some previous resources and topics have been removed.SummaryDifference7%
- Check26 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.9%
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.7%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.6%
Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.